Results 111 to 120 of about 25,504 (187)
Methodological Considerations in Multilevel Comparative Analyses of Robotic Versus Video-Assisted Thoracoscopic Lung Resection. [PDF]
Swaika S, Dhyani A, Kumar R, Arora H.
europepmc +1 more source
This study demonstrated anatomic lung resection using the da Vinci SP, a novel single‐port robot‐assisted thoracoscopic approach, yields outcomes comparable to those achieved with the da Vinci Xi.ABSTRACTBackgroundThe da Vinci SP enables single‐port robot‐assisted thoracoscopic surgery and this modality represents a novel approach to lung resection via
Teruhisa Kawaguchi +4 more
wiley +1 more source
Intercostal nerve blocks should set the standard for regional analgesia in video-assisted thoracic surgery. [PDF]
Coppens S.
europepmc +1 more source
This graphical abstract summarizes outcomes in 106 octogenarian lung cancer patients managed with minimally invasive surgery under ERAS. Sublobar resection was associated with faster recovery than lobectomy, with shorter length of stay and chest tube duration.
Qixuan Wang +5 more
wiley +1 more source
Fully uniportal robotic-assisted lobectomy using da Vinci Xi system: surgical technique for a fifth intercostal approach with the cross-arm technique. [PDF]
Hashimoto K, Sengoku H, Date S.
europepmc +1 more source
Abnormal preoperative pulmonary function tests and lower FEV1 were independently associated with an increased risk of postoperative pulmonary complications in patients undergoing noncardiac surgery. ABSTRACT Background Postoperative pulmonary complications (PPCs) increase surgical morbidity and mortality.
Sung Ae Cho, Hee Eun Kim, Moon Ok Lee
wiley +1 more source
Surgical treatment of acute empyema caused by methicillin-resistant <i>Staphylococcus aureus</i> in a patient with advanced non-small cell lung cancer: a case report. [PDF]
Motono N +4 more
europepmc +1 more source
Abstract Background and aims Tissue‐retained needles from intravenous drug use can cause rare but severe complications, ranging from local to systemic infections to needle embolization. Due to the limited evidence and the lack of epidemiological studies on the issue, we systematically reviewed the literature focusing on case reports and case series on ...
Heidi Laukkala +7 more
wiley +1 more source
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source

